Hitherto, medication like sodium–glucose cotransporter 2 (SGLT-2) inhibitors are recommended in heart failure and statins in hyperlipidemia guidelines and are known to exhibit anti-inflammatory properties [79,80]. The gene discussed is SLC5A2; the disease is heart failure.